KTB TUMORFORSCHUNGSGESELLSCHAFT MBH Patent applications |
Patent application number | Title | Published |
20150174539 | APPARATUS FOR THE HOMOGENIZATION AND SEPARATION OF SAMPLES - The invention relates to an apparatus for the homogenization and separation of media ( | 06-25-2015 |
20140205539 | Dual Acting Prodrugs - The present invention relates to a prodrug which comprises at least two different pharmaceutically and/or diagnostically active compounds independently bound by cleavable linkers and a protein-binding moiety which is capable of binding to carrier a molecule. | 07-24-2014 |
20140051623 | Bisphosphonate-Prodrugs - The present invention relates to a prodrug, comprising a pharmaceutically and/or diagnostically active compound, and one or more bisphosphonate groups, to a process for producing such a prodrug, and to a pharmaceutical composition comprising said prodrug, to be used for the treatment of bone-related disorders such as bone cancer. | 02-20-2014 |
20130040905 | Combination Of Drugs With Protein-Binding Prodrugs - The present invention relates to a composition and a combination comprising at least one first drug and at least one protein-binding prodrug, wherein the proteinbinding prodrug comprises a protein-binding group, a second drug, and a linker that can be cleaved hydrolytically, enzymatically, or in a pH-dependent manner in the body, as well as to a kit and a pharmaceutical composition comprising said composition or combination. | 02-14-2013 |
20130012473 | COMBINED USE OF PHOSPHOLIPID AND SULFATE GROUPS-CARRYING POLYSACCHARIDES FOR INHIBITING METASTATIC SPREAD - The invention relates to a medicament comprising a phospholipid component and a polysaccharide component having polysaccharides containing sulfate groups for inhibiting metastatic spread of tumors. The two components may be in same or separate preparation. | 01-10-2013 |
20120165296 | BISPHOSPHONATE-PRODRUGS - The present invention relates to a prodrug, comprising a pharmaceutically and/or diagnostically active compound, and one or more bisphosphonate groups, to a process for producing such a prodrug, and to a pharmaceutical composition comprising said prodrug, to be used for the treatment of bone-related disorders such as bone cancer. | 06-28-2012 |
20120142711 | ACID-LABILE TRIGGER UNITS - The present invention relates to a compound comprising an imine bond as an acid-labile trigger group, the use of such an imine bond as an acid-labile trigger group, a process of cleaving the imine bond in said compound, and a pharmaceutical composition comprising said compound. | 06-07-2012 |
20120094892 | PRODRUGS - The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer. | 04-19-2012 |
20110117009 | DRUG CONJUGATES WITH POLYGLYCEROLS - The present invention relates to a drug polymer conjugate comprising a pharmaceutically active compound and a dendritic polyglycerol, as well as to a drug polymer conjugate comprising a pharmaceutically and/or diagnostically active compound bound to a dendritic polyglycerol core having a polyethylene glycol shell. | 05-19-2011 |
20100152273 | LOW-VISCOUS ANTHRACYCLINE FORMULATION - The present invention relates to formulations comprising an anthracycline compound and an aromatic or heterocyclic compound. | 06-17-2010 |
20100144647 | Dual Acting Prodrugs - The present invention relates to a prodrug which comprises at least two different pharmaceutically and/or diagnostically active compounds independently bound by cleavable linkers and a protein-binding moiety which is capable of binding to carrier a molecule. | 06-10-2010 |
20100111866 | Receptor and Antigen Targeted Prodrug - The present invention relates to a prodrug which comprises at least one pharmaceutically and/or diagnostically active compound bound by a cleavable linker, a receptor and/or antigen targeting moiety and a protein-binding moiety which is capable of binding to a carrier molecule. | 05-06-2010 |
20090298793 | Acylgycerophospholipids for treating symptoms concomitant with cancer - The invention relates to the use of acylglycerophospholipids, in particular of hydrogenated acylglycerophospholipids and of phospholipids with a high omega-3 fatty acid content, for the production of a medicament for treating symptoms concomitant with cancer, in particular for treating tumour cachexia, cancer-related problems and pain, and for the prophylaxis of tumour growth and metastasis. | 12-03-2009 |